-- Gushengtang Holdings' (HKG:2273) board proposed raising the ceiling of its share repurchase program by a further HK$300 million, according to a Hong Kong bourse filing Tuesday.
Shares of the traditional Chinese medicine firm gained over 8% in morning trade Wednesday.
The firm previously launched a HK$300 million share buyback in August 2025, which was expanded by a further HK$300 million in November 2025.
The latest buyback will commence after shareholder approval.
Meanwhile, in a separate statement, the firm said customer visits for the three months ended March 31 rose 15% to around 1.39 million from 1.21 million a year prior.